Alyeska Investment Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
346,089
-3,105
| -0.9% | -$11.7K | ﹤0.01% | 492 |
|
|
2025
Q1 | $1.58M | Sell |
349,194
-1,670,186
| -83% | -$7.57M | 0.01% | 420 |
|
|
2024
Q4 | $14.3M | Buy |
2,019,380
+861,150
| +74% | +$6.09M | 0.05% | 295 |
|
|
2024
Q3 | $9.43M | Buy |
1,158,230
+173,670
| +18% | +$1.41M | 0.05% | 300 |
|
|
2024
Q2 | $6.29M | Hold |
984,560
| – | – | 0.04% | 310 |
|
|
2024
Q1 | $7.41M | Buy |
984,560
+100,000
| +11% | +$753K | 0.05% | 295 |
|
|
2023
Q4 | $8.19M | Sell |
884,560
-33,769
| -4% | -$313K | 0.05% | 274 |
|
|
2023
Q3 | $9.29M | Buy |
918,329
+20,315
| +2% | +$206K | 0.06% | 288 |
|
|
2023
Q2 | $11.2M | Buy |
898,014
+150,644
| +20% | +$1.88M | 0.08% | 250 |
|
|
2023
Q1 | $8.72M | Buy |
747,370
+20,404
| +3% | +$238K | 0.08% | 254 |
|
|
2022
Q4 | $7.73M | Buy |
726,966
+55,500
| +8% | +$590K | 0.08% | 226 |
|
|
2022
Q3 | $6.51M | Buy |
+671,466
| New | +$6.51M | 0.08% | 240 |
|
|
2021
Q4 | – | Sell |
-50,000
| Closed | -$2.5M | – | 663 |
|
|
2021
Q3 | $2.5M | Buy |
+50,000
| New | +$2.5M | 0.03% | 460 |
|
|
2020
Q3 | – | Sell |
-214,799
| Closed | -$6.27M | – | 518 |
|
|
2020
Q2 | $6.27M | Sell |
214,799
-151,058
| -41% | -$4.41M | 0.1% | 240 |
|
|
2020
Q1 | $9.57M | Buy |
365,857
+54,261
| +17% | +$1.42M | 0.19% | 132 |
|
|
2019
Q4 | $10.8M | Buy |
311,596
+215,547
| +224% | +$7.48M | 0.14% | 160 |
|
|
2019
Q3 | $3.04M | Buy |
+96,049
| New | +$3.04M | 0.04% | 252 |
|